Survey finds gap between trial availability and patient need in glioblastoma

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

People with glioblastoma are being deprived of the best chance of survival: easy access to clinical trials and off-label treatments, according to a survey of 162 patients and caregivers conducted by OurBrainBank.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login